{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:59:00Z","timestamp":1776157140768,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR11807\/MED\/29\/871\/2014"],"award-info":[{"award-number":["BT\/PR11807\/MED\/29\/871\/2014"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12896-016-0280-y","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T06:55:07Z","timestamp":1465887307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies"],"prefix":"10.1186","volume":"16","author":[{"given":"Ankur","family":"Poddar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanathan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Kant","family":"Rajpoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upasana","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swatantra K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathyamangalam","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navin","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"key":"280_CR1","first-page":"1153","volume-title":"Fields Virology","author":"DJ Gubler","year":"2007","unstructured":"Gubler DJ, Kuno G, Markoff L. Flaviviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer and Lippincott Williams & Wilkins; 2007. p. 1153\u2013252.","edition":"5"},{"issue":"7446","key":"280_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504\u20137.","journal-title":"Nature"},{"key":"280_CR3","first-page":"1101","volume-title":"Fields of Virology","author":"BD Lindenbach","year":"2007","unstructured":"Lindenbach BD, Thiel HJ, Rice CM. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, editors. Fields of Virology. 5th ed. Philadelphia: Wolters Kluwer and Lippincott Williams & Wilkins; 2007. p. 1101\u201352.","edition":"5"},{"key":"280_CR4","unstructured":"WHO Factsheet No117. Dengue and dengue haemorrhagic fever. 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs117\/en\/ . Accessed 2016 Mar 6."},{"issue":"2","key":"280_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/156652409787581592","volume":"9","author":"S Swaminathan","year":"2009","unstructured":"Swaminathan S, Khanna N. Dengue: recent advances in biology and current status of translational research. Curr Mol Med. 2009;9(2):152\u201373.","journal-title":"Curr Mol Med"},{"key":"280_CR6","first-page":"221","volume-title":"Dengue and Dengue Hemorrhagic Fever","author":"BL Innis","year":"1997","unstructured":"Innis BL. Antibody responses to dengue virus infection. In: Gubler DJ, Kuno G, editors. Dengue and Dengue Hemorrhagic Fever. Wallingford: CAB International; 1997. p. 221\u201343."},{"key":"280_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","volume":"60","author":"SB Halstead","year":"2003","unstructured":"Halstead SB. Neutralization and antibody dependent enhancement of dengue viruses. Adv Virus Res. 2003;60:421\u201367.","journal-title":"Adv Virus Res"},{"issue":"6","key":"280_CR8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/13543771003767476","volume":"20","author":"S Swaminathan","year":"2010","unstructured":"Swaminathan S, Batra G, Khanna N. Dengue vaccines: state of the art. Expert Opin Ther Patents. 2010;20(6):819\u201335.","journal-title":"Expert Opin Ther Patents"},{"issue":"9951","key":"280_CR9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunandh T, Chua MN, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358\u201365.","journal-title":"Lancet"},{"key":"280_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2015","unstructured":"Villar L, Dayan GH, Arredondo-Garc\u00eda JL, Rivera DM, Cunha R, Deseda C, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. New Eng J Med. 2015;372:113\u201323.","journal-title":"New Eng J Med"},{"key":"280_CR11","unstructured":"WHO.2015. http:\/\/www.who.int\/immunization\/research\/development\/dengue_vaccines\/en\/ .Accessed 2016 Mar 6"},{"issue":"11","key":"280_CR12","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","volume":"89","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Chan KW, Wang J, Rivino L, Lok SM, Vasudevan SG. Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice. J Virol. 2015;89(11):5847\u201361.","journal-title":"J Virol"},{"issue":"5","key":"280_CR13","doi-asserted-by":"crossref","first-page":"e64595","DOI":"10.1371\/journal.pone.0064595","volume":"8","author":"S Mani","year":"2013","unstructured":"Mani S, Tripathi L, Raut R, Tyagi P, Arora U, Barman T, et al. Pichia pastoris-expressed dengue 2 envelope forms virus-Like particles without pre-membrane protein and induces high titer neutralizing antibodies. PLoS One. 2013;8(5):e64595.","journal-title":"PLoS One"},{"key":"280_CR14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fmicb.2015.01005","volume":"6","author":"L Tripathi","year":"2015","unstructured":"Tripathi L, Mani S, Raut R, Poddar A, Tyagi P, Arora U, et al. Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies. Frontiers Microbiol. 2015;6:1005.","journal-title":"Frontiers Microbiol"},{"issue":"12","key":"280_CR15","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Y Modis","year":"2003","unstructured":"Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003;100(12):6986\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"280_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","volume":"366","author":"GD Gromowski","year":"2007","unstructured":"Gromowski GD, Barrett AD. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology. 2007;366(2):349\u201360.","journal-title":"Virology"},{"issue":"4","key":"280_CR17","doi-asserted-by":"crossref","first-page":"e1000823","DOI":"10.1371\/journal.ppat.1000823","volume":"6","author":"B Shrestha","year":"2010","unstructured":"Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, et al. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 2010;6(4):e1000823.","journal-title":"PLoS Pathog"},{"issue":"5979","key":"280_CR18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328(5979):745\u20138.","journal-title":"Science"},{"issue":"1","key":"280_CR19","doi-asserted-by":"crossref","first-page":"e1000718","DOI":"10.1371\/journal.ppat.1000718","volume":"6","author":"IA Rodenhuis-Zybert","year":"2010","unstructured":"Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, Wilschut J, et al. Immature dengue virus: a veiled pathogen? PLoS Pathog. 2010;6(1):e1000718.","journal-title":"PLoS Pathog"},{"issue":"4","key":"280_CR20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.2.4.3015","volume":"2","author":"Q Zhao","year":"2006","unstructured":"Zhao Q, Wang Y, Freed D, Fu TM, Gimenez JA, Sitrin RD, et al. Maturation of recombinant hepatitis B virus surface antigen particles. Hum Vaccin. 2006;2(4):174\u201380.","journal-title":"Hum Vaccin"},{"key":"280_CR21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nchembio.1403","volume":"9","author":"MA Wolfert","year":"2013","unstructured":"Wolfert MA, Boons G-J. Adaptive immune activation: glycosylation does matter. Nat Chem Biol. 2013;9:776\u201384.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"280_CR22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","volume":"31","author":"EA Henchal","year":"1982","unstructured":"Henchal EA, Gentry MK, McCown JM, Bandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg. 1982;31(4):830\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"280_CR23","doi-asserted-by":"crossref","first-page":"e1000821","DOI":"10.1371\/journal.ppat.1000821","volume":"6","author":"WMPB Wahala","year":"2010","unstructured":"Wahala WMPB, Donaldson EF, de Alwis R, Accavitti-Loper MA, Baric RS, de Silva AM. Natural strain variation and antibody neutralization of dengue serotype 3 viruses. PLoS Pathog. 2010;6(3):e1000821.","journal-title":"PLoS Pathog"},{"issue":"16","key":"280_CR24","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01314-13","volume":"87","author":"S Sukupolvi-Petty","year":"2013","unstructured":"Sukupolvi-Petty S, Brien JD, Austin SK, Shrestha B, Swayne S, Kahle K, et al. Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J Virol. 2013;87(16):8826\u201342.","journal-title":"J Virol"},{"issue":"20","key":"280_CR25","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","volume":"84","author":"JD Brien","year":"2010","unstructured":"Brien JD, Austin SK, Sukupolvi-Petty S, O\u2019Brien KM, Johnson S, Fremont DH, et al. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol. 2010;84(20):10630\u201343.","journal-title":"J Virol"},{"issue":"6","key":"280_CR26","first-page":"e00873","volume":"4","author":"SA Smith","year":"2013","unstructured":"Smith SA, de Alwis R, Kose N, Harris E, Ibarra KD, Kahle KM, et al. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc Loop of domain II of the envelope protein. mBio. 2013;4(6):e00873\u201313.","journal-title":"mBio"},{"issue":"10","key":"280_CR27","doi-asserted-by":"crossref","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","volume":"10","author":"R Alwis De","year":"2014","unstructured":"De Alwis R, Williams KL, Schmid MA, Lai C-Y, Patel B, Smith SA, et al. Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera. PLoS Pathog. 2014;10(10):e1004386.","journal-title":"PLoS Pathog"},{"key":"280_CR28","unstructured":"WHO Report. 2012. http:\/\/www.who.int\/neglected_diseases\/2012report\/en\/ . Accessed 2016 March 6."},{"issue":"1","key":"280_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","volume":"14","author":"B Guy","year":"2016","unstructured":"Guy B, Jackson N. Dengue vaccine: hypothesis to understand CYD-TDV-induced protection. Natur Rev Microbiol. 2016;14(1):45\u201354.","journal-title":"Natur Rev Microbiol"},{"issue":"2","key":"280_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1586\/erv.10.159","volume":"10","author":"R Edelman","year":"2011","unstructured":"Edelman R. Unique challenges faced by the clinical evaluation of dengue vaccines. Expert Rev Vaccines. 2011;10(2):133\u20136.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"280_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jiq060","volume":"203","author":"SJ Thomas","year":"2011","unstructured":"Thomas SJ. The necessity and quandaries of dengue vaccine development. J Infect Dis. 2011;203(3):299\u2013303.","journal-title":"J Infect Dis"},{"issue":"3","key":"280_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(13)70028-8","volume":"13","author":"S Swaminathan","year":"2013","unstructured":"Swaminathan S, Khanna N, Herring B, Mahalingam S. Dengue vaccine efficacy trial: does interference cause failure? Lancet Infect Dis. 2013;13(3):191\u20132.","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"280_CR33","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1016\/j.vaccine.2011.07.017","volume":"29","author":"J Schmitz","year":"2011","unstructured":"Schmitz J, Roehrig J, Barrett A, Hombach J. Next generation dengue vaccines: a review of candidates in preclinical development. Vaccine. 2011;29(42):7276\u201384.","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"280_CR34","doi-asserted-by":"crossref","first-page":"S573","DOI":"10.1016\/S2222-1808(14)60681-2","volume":"4","author":"R Venkatachalam","year":"2014","unstructured":"Venkatachalam R, Subramaniyan V. Homology and conservation of amino acids in E-protein sequences of dengue serotypes. Asian Pacific Journal of Tropical Disease. 2014;4 Suppl 2:S573\u20137.","journal-title":"Asian Pacific Journal of Tropical Disease"},{"issue":"5","key":"280_CR35","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JVI.06335-11","volume":"86","author":"SA Smith","year":"2012","unstructured":"Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe Jr JE. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following Infection. J Virol. 2012;86(5):2665\u201375.","journal-title":"J Virol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-016-0280-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:20:46Z","timestamp":1498306846000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-016-0280-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1186\/s12896-016-0280-y","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]},"article-number":"50"}}